﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticalData xmlns:xsi="http://www.consortiumpublisher.com" xmlns="http://www.consortiumpublisher.com">
  <Header>
    <ArticleTitle>VANCOMYCIN ASSOCIATED EOSINOPHILIA &amp; RED MAN SYNDROMEIN A TERTIARY CARE HOSPITAL</ArticleTitle>
  </Header>
  <ArticleParameters>
    <ArticleReceivingDate>2015-04-15</ArticleReceivingDate>
    <ArticleAcceptanceDate>2015-04-25</ArticleAcceptanceDate>
    <ArticlePublishedOn>11/12/2024 6:35:19 AM</ArticlePublishedOn>
  </ArticleParameters>
  <Authors>
    <ArticleAuthors>Adeel Siddiqui, Zuhaib Jaffer Malik, Sidrah Andleeb</ArticleAuthors>
  </Authors>
  <keywords>
    <Articlekeywords>red man syndrome, vancomycin, drug rash eosinophilia and systemic symptoms, eosinophilia.</Articlekeywords>
  </keywords>
  <Abstract>
    <ArticleAbstract>Vancomycin associated Red Man Syndrome (RMS) is a common infusion related adverse effect. A correlation has been proposed between vancomycin induced eosinophilia and occurrence of RMS.In such cases, it is identified that activated T-cells release cytokines, which tends to contribute to hypersensitivity reaction.A cross-sectional, retrospective study was conducted to evaluate the possible association of vancomycin induced eosinophilia with the occurrence of RMS at a local tertiary care cancer hospital. In this study the role of eosinophilia before the occurrence of RMS was focused. A twenty one month data was extracted from Jan, 2014 to Sep, 2015 and 8 patients were found to be reported for vancomycin induced RMS. Only one patient (12.5%) fulfilled the criteria for the drug rash eosinophilia and systemic symptoms (DRESS) among the 8 patients. This particular patient had eosinophilia preceding RMS. In the study sample,2(25%) patients showed a rise in their eosinophil count but within the normal range.A correlation of eosinophilia and RMScould not be established in our study.</ArticleAbstract>
  </Abstract>
</ArticalData>